RED BLOOD-CELL SORBITOL LOWERING EFFECTS AND TOLERANCE OF SINGLE DOSES OF AL1576 (HOE 843) IN DIABETIC-PATIENTS

被引：8
作者：
AVERBUCH, M
WEINTRAUB, M
LIAO, JC
BRAZZELL, RK
DOBBS, RE
机构：
[1] UNIV ROCHESTER,SCH MED & DENT,DEPT PREVENT MED,ROCHESTER,NY 14642
[2] ALCON LABS INC,FT WORTH,TX 76101
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 28卷 / 08期
关键词：
D O I：
10.1002/j.1552-4604.1988.tb03211.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：757 / 761
页数：5
相关论文
共 33 条
[1]   THE POLYOL PATHWAY, SORBINIL, AND RENAL DYSFUNCTION [J].
BEYERMEARS, A .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1986, 35 (04) :46-54
[2]   GLOMERULAR POLYOL ACCUMULATION IN DIABETES AND ITS PREVENTION BY ORAL SORBINIL [J].
BEYERMEARS, A ;
KU, L ;
COHEN, MP .
DIABETES, 1984, 33 (06) :604-607
[3]  
BROWN BA, 1976, HEMATOLOGY PRINCIPLE, P71
[4]  
CHANDLER M L, 1982, Investigative Ophthalmology and Visual Science, V22, P156
[5]  
CHANDLER ML, 1984, INVEST OPHTHALMOL S, V25, P159
[6]   ALDOSE REDUCTASE AND COMPLICATIONS OF DIABETES [J].
COGAN, DG ;
KINOSHITA, JH ;
KADOR, PF ;
ROBISON, WG ;
DATILIS, MB ;
COBO, LM ;
KUPFER, C .
ANNALS OF INTERNAL MEDICINE, 1984, 101 (01) :82-91
[7]   THE RENAL EXCRETION OF INOSITOL IN NORMAL AND DIABETIC HUMAN BEINGS [J].
DAUGHADAY, WH ;
LARNER, J .
JOURNAL OF CLINICAL INVESTIGATION, 1954, 33 (03) :326-332
[8]   EFFECTS OF ALDOSE REDUCTASE INHIBITOR TREATMENT IN DIABETIC POLYNEUROPATHY - A CLINICAL AND NEUROPHYSIOLOGICAL STUDY [J].
FAGIUS, J ;
JAMESON, S .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1981, 44 (11) :991-1001
[9]  
FAGIUS J, 1985, DIABETOLOGIA, V28, P323
[10]   POLYOL PATHWAY ACTIVITY AND MYOINOSITOL METABOLISM - A SUGGESTED RELATIONSHIP IN THE PATHOGENESIS OF DIABETIC NEUROPATHY [J].
FINEGOLD, D ;
LATTIMER, SA ;
NOLLE, S ;
BERNSTEIN, M ;
GREENE, DA .
DIABETES, 1983, 32 (11) :988-992
1234